Previous close | 50.58 |
Open | 50.82 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 50.26 - 50.82 |
52-week range | 33.27 - 54.90 |
Volume | |
Avg. volume | 236,987 |
Market cap | N/A |
Beta (5Y monthly) | 0.57 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 30 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 38.30 |
Pfizer ( NYSE:PFE ) First Quarter 2024 Results Key Financial Results Revenue: US$14.9b (down 19% from 1Q 2023). Net...
NEW YORK, May 06, 2024--Pfizer Inc. (NYSE: PFE) today announced that Andrew Baum, M.D., will join the company as Chief Strategy and Innovation Officer, Executive Vice President. Dr. Baum will be a member of Pfizer’s Executive Leadership Team reporting to Chairman and Chief Executive Officer, Dr. Albert Bourla. He joins Pfizer from Citi, where he served as Head of Global Healthcare, Managing Director Equity Research. Prior to joining Citi in 2011, Dr. Baum covered European Pharmaceuticals at Morg
Readers hoping to buy Pfizer Inc. ( NYSE:PFE ) for its dividend will need to make their move shortly, as the stock is...